total hip arthroplasty
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: This study included all patients undergoing primary unilateral THA via DAA at our institution between September 2020 and September 2021. To be enrolled, patients had to be diagnosed with osteoarthritis of the hip, osteonecrosis of the femoral head (Ficat IIIB or IV), and Crowe Type I or II dysplasia; and they had to have an American Society of Anesthesiologists functional status of I III.
Exclusion criteria
Exclusion criteria: (1) Body mass index (BMI) > 30 kg/m2; (2) Crowe Type III or IV dysplasia; (3) previous hip open surgery; (4) an inability to tolerate general anesthesia; (5) known allergies to the drugs administered in this study, or (6) an unwillingness to participate in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SCAR score;Satisfaction with scar;VAS pain score;Daily ambulation distance;Oxford hip score;UCLA activity-level rating;Postoperative hospital stay; | — |
Countries
China
Contacts
Affiliated Hospital of Xuzhou Medical University